Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...
At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...